Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by XX% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2023 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by XX% in 2023, of which the U.S. economy will grow by about XX%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2023. However, China's economic growth has slowed down. The 2023 government work report shows that the expected target of economic growth is set at about XX%.
According to research, China has set a growth rate of about XX%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2023, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
VIC Research released the 《Global Human Primary Cells Market Segment Research Report 2023》, which aims to sort out the development status and trends of the Human Primary Cells industry at home and abroad, estimate the overall market scale of the Human Primary Cells industry and the market share of major countries, Human Primary Cells industry, and study and judge the downstream market demand of Human Primary Cells through systematic research, Analyze the competition pattern of Human Primary Cells, so as to help solve the pain points of various stakeholders in Human Primary Cells industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2019-2029) of Human Primary Cells Market by VIC Research Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Human Primary Cells Market?
Lonza
Thermo Fisher Scientific
Sigma-Aldrich
Cell Biologics
PromoCell GmbH
Cureline
Zen-Bio
STEMCELL Technologies
Cell Applications
Pelobiotech
Creative Bioarray
Charles River Laboratories
Axol Bioscience
ReachBio Research Labs
Major Type of Human Primary Cells Covered in VIC Research report:
Epithelial Cells
Fibroblasts
Hematopoietic
Liver Cells
Mesenchymal Stem Cells
Muscle Cells
Pericytes
Application Segments Covered in VIC Research Market
Medical
Santific Research
Other
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Human Primary Cells Market Segment Research Report 2023
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Human Primary Cells Market by Value
2.2.1 Global Human Primary Cells Revenue by Type
2.2.2 Global Human Primary Cells Market by Value
2.3 Global Human Primary Cells Market by Sales
2.3.1 Global Human Primary Cells Sales by Type
2.3.2 Global Human Primary Cells Market by Sales
3. The Major Driver of Human Primary Cells Industry
3.1 Historical & Forecast Global Human Primary Cells Sales and Revenue (2019-2029)
3.2 Largest Application for Human Primary Cells (2019-2029)
3.3 The Major Downstream Company in China Market 2023
4. Global and Regional Human Primary Cells Market
4.1 Regional Market Size in Terms of Sales (2023 & 2029)
4.2 Regional Market Share in Terms of Revenue (2023 & 2029)
4.3 Concentration Ratio (CR5& CR10) of Human Primary Cells Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Human Primary Cells Sales (2019-2029)
5.1 Current and Estimated Sales Breakdown by Type (2019-2029)
5.2 Current and Estimated Sales Breakdown by Application (2019-2029)
5.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
5.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
6. Europe Human Primary Cells Sales (2019-2029)
6.1 Current and Estimated Sales Breakdown by Type (2019-2029)
6.2 Current and Estimated Sales Breakdown by Application (2019-2029)
6.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
6.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
7. China Human Primary Cells Sales (2019-2029)
7.1 Current and Estimated Sales Breakdown by Type (2019-2029)
7.2 Current and Estimated Sales Breakdown by Application (2019-2029)
7.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
7.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
8. Japan Human Primary Cells Sales (2019-2029)
8.1 Current and Estimated Sales Breakdown by Type (2019-2029)
8.2 Current and Estimated Sales Breakdown by Application (2019-2029)
8.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
8.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
9. India Human Primary Cells Sales (2019-2029)
9.1 Current and Estimated Sales Breakdown by Type (2019-2029)
9.2 Current and Estimated Sales Breakdown by Application (2019-2029)
9.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
9.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
10. Korea Human Primary Cells Sales (2019-2029)
10.1 Current and Estimated Sales Breakdown by Type (2019-2029)
10.2 Current and Estimated Sales Breakdown by Application (2019-2029)
10.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
10.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
11. Southeast Asia Human Primary Cells Sales (2019-2029)
11.1 Current and Estimated Sales Breakdown by Type (2019-2029)
11.2 Current and Estimated Sales Breakdown by Application (2019-2029)
11.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
11.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
12. South America Human Primary Cells Sales (2019-2029)
12.1 Current and Estimated Sales Breakdown by Type (2019-2029)
12.2 Current and Estimated Sales Breakdown by Application (2019-2029)
12.3 Current and Estimated Revenue Breakdown by Type (2019-2029)
12.4 Current and Estimated Revenue Breakdown by Application (2019-2029)
13. Global Human Primary Cells Average Price Trend
13.1 Market Price for Each Type of Human Primary Cells in US (2019-2023)
13.2 Market Price for Each Type of Human Primary Cells in Europe (2019-2023)
13.3 Market Price for Each Type of Human Primary Cells in China (2019-2023)
13.4 Market Price for Each Type of Human Primary Cells in Japan (2019-2023)
13.5 Market Price for Each Type of Human Primary Cells in India (2019-2023)
13.6 Market Price for Each Type of Human Primary Cells in Korea (2019-2023)
13.7 Market Price for Each Type of Human Primary Cells in Southeast Asia (2019-2023)
13.8 Market Price for Each Type of Human Primary Cells in South America (2019-2023)
14. Industrial Chain (Impact of COVID-19)
14.1 Human Primary Cells Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Human Primary Cells
15. Human Primary Cells Competitive Landscape
15.1 Lonza
15.1.1 Lonza Company Profiles
15.1.2 Lonza Product Introduction
15.1.3 Lonza Human Primary Cells Sales, Revenue (2019-2023)
15.1.4 Strategic initiatives
15.2 Thermo Fisher Scientific
15.2.1 Thermo Fisher Scientific Company Profiles
15.2.2 Thermo Fisher Scientific Product Introduction
15.2.3 Thermo Fisher Scientific Human Primary Cells Sales, Revenue (2019-2023)
15.2.4 Strategic initiatives
15.3 Sigma-Aldrich
15.3.1 Sigma-Aldrich Company Profiles
15.3.2 Sigma-Aldrich Product Introduction
15.3.3 Sigma-Aldrich Human Primary Cells Sales, Revenue (2019-2023)
15.3.4 Strategic initiatives
15.4 Cell Biologics
15.4.1 Cell Biologics Company Profiles
15.4.2 Cell Biologics Product Introduction
15.4.3 Cell Biologics Human Primary Cells Sales, Revenue (2019-2023)
15.4.4 Strategic initiatives
15.5 PromoCell GmbH
15.5.1 PromoCell GmbH Company Profiles
15.5.2 PromoCell GmbH Product Introduction
15.5.3 PromoCell GmbH Human Primary Cells Sales, Revenue (2019-2023)
15.5.4 Strategic initiatives
15.6 Cureline
15.6.1 Cureline Company Profiles
15.6.2 Cureline Product Introduction
15.6.3 Cureline Human Primary Cells Sales, Revenue (2019-2023)
15.6.4 Strategic initiatives
15.7 Zen-Bio
15.7.1 Zen-Bio Company Profiles
15.7.2 Zen-Bio Product Introduction
15.7.3 Zen-Bio Human Primary Cells Sales, Revenue (2019-2023)
15.7.4 Strategic initiatives
15.8 STEMCELL Technologies
15.8.1 STEMCELL Technologies Company Profiles
15.8.2 STEMCELL Technologies Product Introduction
15.8.3 STEMCELL Technologies Human Primary Cells Sales, Revenue (2019-2023)
15.8.4 Strategic initiatives
15.9 Cell Applications
15.9.1 Cell Applications Company Profiles
15.9.2 Cell Applications Product Introduction
15.9.3 Cell Applications Human Primary Cells Sales, Revenue (2019-2023)
15.9.4 Strategic initiatives
15.10 Pelobiotech
15.10.1 Pelobiotech Company Profiles
15.10.2 Pelobiotech Product Introduction
15.10.3 Pelobiotech Human Primary Cells Sales, Revenue (2019-2023)
15.10.4 Strategic initiatives
15.11 Creative Bioarray
15.12 Charles River Laboratories
15.13 Axol Bioscience
15.14 ReachBio Research Labs
16. Conclusion
17. Methodology and Data Source
List of Tables and Figures
Figure 1. Total Sales by Application of Human Primary Cells Industry (Volume)
Figure 2. Human Primary Cells Sales by Regions in 2023
Figure 3. Regional Market Share in Terms of Revenue (2023&2029)
Figure 4. The Top 10 and 5 Players Market Share by Human Primary Cells Revenue in 2023
Figure 5. US Human Primary Cells Sales (2019-2029)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Human Primary Cells Sales (2019-2029)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Human Primary Cells Sales (2019-2029)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Human Primary Cells Sales (2019-2029)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Human Primary Cells Sales (2019-2029)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Human Primary Cells Sales (2019-2029)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Human Primary Cells Sales (2019-2029)
Figure 43. Current and Estimated Sales Breakdown by Type (2019-2029)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Human Primary Cells Revenue, by Type (Million USD) (2019-2029)
Table 4. Human Primary Cells Sales, by Type (K Unit) (2019-2029)
Table 5. Human Primary Cells Sales (K Unit) by Application (2019-2029)
Table 6. Human Primary Cells Sales (Million USD) by Application (2019-2029)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2023)
Table 9. Regional Market Share in Terms of Revenue (2023&2029)
Table 10. Ranking of Global Top Human Primary Cells Companies by Revenue, Concentration Ratio in 2023
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Human Primary Cells Sales (K Unit), Market Revenue (Million USD) (2019-2029)
Table 13. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 14. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 15. Current and Estimated Sales Breakdown by Application (2019-2029)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Human Primary Cells Sales (K Unit), Market Revenue (Million USD) (2019-2029)
Table 19. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 20. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 21. Current and Estimated Sales Breakdown by Application (2019-2029)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Human Primary Cells Sales (K Unit), Market Revenue (Million USD) (2019-2029)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Human Primary Cells Sales (K Unit), Market Revenue (Million USD) (2019-2029)
Table 30. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 31. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 32. Current and Estimated Sales Breakdown by Application (2019-2029)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Human Primary Cells Sales (K Unit), Market Revenue (Million USD) (2019-2029)
Table 36. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 37. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 38. Current and Estimated Sales Breakdown by Application (2019-2029)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Human Primary Cells Sales (K Unit), Market Revenue (Million USD) (2019-2029)
Table 42. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 43. Current and Estimated Sales Breakdown by Type (2019-2029)
Table 44. Current and Estimated Sales Breakdown by Application (2019-2029)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Human Primary Cells Sales (K Unit), Market Revenue (Million USD) (2019-2029)
Table 48. Table Current and Estimated Sales Breakdown by Type (2019-2029)
Table 49. Current and Estimated Sales Breakdown by Application (2019-2029)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Human Primary Cells in US (2019-2023)
Table 53. Market Price (USD/Unit) for Each Type of Human Primary Cells in Europe (2019-2023)
Table 54. Market Price (USD/Unit) for Each Type of Human Primary Cells in China (2019-2023)
Table 55. Market Price (USD/Unit) for Each Type of Human Primary Cells in Japan (2019-2023)
Table 56. Market Price (USD/Unit) for Each Type of Human Primary Cells in India (2019-2023)
Table 57. Market Price (USD/Unit) for Each Type of Human Primary Cells in Korea (2019-2023)
Table 58. Market Price (USD/Unit) for Each Type of Human Primary Cells in Southeast Asia (2019-2023)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Lonza Profiles
Table 61. Lonza Human Primary Cells Product Introduction
Table 62. Lonza Human Primary Cells Sales (Unit), Revenue (Million USD) (2019-2023)
Table 63. Lonza Strategic initiatives
Table 64. Thermo Fisher Scientific Profiles
Table 65. Thermo Fisher Scientific Human Primary Cells Product Introduction
Table 66. Thermo Fisher Scientific Human Primary Cells Sales (Unit), Revenue (Million USD) (2019-2023)
Table 67. Thermo Fisher Scientific Strategic initiatives
Table 68. Sigma-Aldrich Profiles
Table 69. Sigma-Aldrich Human Primary Cells Product Introduction
Table 70. Sigma-Aldrich Human Primary Cells Sales (Unit), Revenue (Million USD) (2019-2023)
Table 71. Sigma-Aldrich Strategic initiatives
Table 72. Cell Biologics Profiles
Table 73. Cell Biologics Human Primary Cells Product Introduction
Table 74. Cell Biologics Human Primary Cells Sales (Unit), Revenue (Million USD) (2019-2023)
Table 75. Cell Biologics Strategic initiatives
Table 76. PromoCell GmbH Profiles
Table 77. PromoCell GmbH Human Primary Cells Product Introduction
Table 78. PromoCell GmbH Human Primary Cells Sales (Unit), Revenue (Million USD) (2019-2023)
Table 79. PromoCell GmbH Strategic initiatives
Table 80. Cureline Profiles
Table 81. Cureline Human Primary Cells Product Introduction
Table 82. Cureline Human Primary Cells Sales (Unit), Revenue (Million USD) (2019-2023)
Table 83. Cureline Strategic initiatives
Table 84. Zen-Bio Profiles
Table 85. Zen-Bio Human Primary Cells Product Introduction
Table 86. Zen-Bio Human Primary Cells Sales (Unit), Revenue (Million USD) (2019-2023)
Table 87. Zen-Bio Strategic initiatives
Table 88. STEMCELL Technologies Profiles
Table 89. STEMCELL Technologies Human Primary Cells Product Introduction
Table 90. STEMCELL Technologies Human Primary Cells Sales (Unit), Revenue (Million USD) (2019-2023)
Table 91. STEMCELL Technologies Strategic initiatives
Table 92. Cell Applications Profiles
Table 93. Cell Applications Human Primary Cells Product Introduction
Table 94. Cell Applications Human Primary Cells Sales (Unit), Revenue (Million USD) (2019-2023)
Table 95. Cell Applications Strategic initiatives
Table 97. Pelobiotech Profiles
Table 98. Pelobiotech Human Primary Cells Product Introduction
Table 99. Pelobiotech Human Primary Cells Sales (Unit), Revenue (Million USD) (2019-2023)
Table 100. Pelobiotech Strategic initiatives
Table 101. Creative Bioarray Profiles
Table 102. Creative Bioarray Human Primary Cells Product Introduction
Table 103. Creative Bioarray Human Primary Cells Sales (Unit), Revenue (Million USD) (2019-2023)
Table 104. Creative Bioarray Strategic initiatives
Table 105. Charles River Laboratories Profiles
Table 106. Charles River Laboratories Human Primary Cells Product Introduction
Table 107. Charles River Laboratories Human Primary Cells Sales (Unit), Revenue (Million USD) (2019-2023)
Table 108. Charles River Laboratories Strategic initiatives
Table 109. Axol Bioscience Profiles
Table 110. Axol Bioscience Human Primary Cells Product Introduction
Table 111. Axol Bioscience Human Primary Cells Sales (Unit), Revenue (Million USD) (2019-2023)
Table 112. Axol Bioscience Strategic initiatives
Table 113. ReachBio Research Labs Profiles
Table 114. ReachBio Research Labs Human Primary Cells Product Introduction
Table 115. ReachBio Research Labs Human Primary Cells Sales (Unit), Revenue (Million USD) (2019-2023)
Table 116. ReachBio Research Labs Strategic initiatives
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.
Consulting report: +86-15323335301 020-31521856
